Important Parameters in  Cytotoxicity Testing of Nanoparticles

MEINDL, C.; ROBLEGG, E.; PIEBER, T. R.; FRÖHLICH, E.

doi:10.3797/scipharm.cespt.8.LNT01

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).

Conference Report

12 July 2010

1 Page

Important Parameters in Cytotoxicity Testing of Nanoparticles

and

Center for Medical Research, Medical University of Graz, Austria

Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Austria

Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology, Karl-Franzens-University of Graz, Austria

Author to whom correspondence should be addressed.

Sci. Pharm.2010, 78(3), 575;https://doi.org/10.3797/scipharm.cespt.8.LNT01

Version Notes

Order Reprints

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Background: The use of nano-sized materials (NMs) offers exciting new options in technical and medical applications. Adverse effects on cells and organs, however, [...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

A Contribution to the Application of Near-Infrared Spectroscopy for Tablet Analysis: Metformin Hydrochloride Tablets Case Study

Development of Solid Lipid Nanoparticles for Praziquantel Delivery: Particle Size Characterization and Cell Toxicity Assessment